M
acromolecules of DNA, RNA and proteins have intrinsically defined features on the nanoscale and may serve as powerful building blocks for the bottom-up fabrication of nanostructures and nanodevices. The field of DNA nanotechnology [1] [2] [3] is now well established, having its origins in work by Seeman some 30 years ago, and peptides and proteins have also been studied for applications in nanotechnology [4] [5] [6] [7] . The concept of RNA nanotechnology [8] [9] [10] [11] [12] [13] [14] [15] has been around for more than a decade, and the first evidence for the construction of RNA nanoparticles through the self-assembly of several re-engineered natural RNA molecules was reported in 1998 8 . However, interest in RNA nanotechnology has increased in recent years as recognition of its potential for applications in nanomedicine -including the treatment of cancer, viral infection and genetic diseases -has grown (Fig. 1) .
RNA can be designed and manipulated with a level of simplicity that is characteristic of DNA, while displaying flexibility in structure and diversity in function (including enzymatic activities) that is similar to that of proteins. Although RNA nanotechnology is similar to that of DNA in a number of ways, there are important differences between the two disciplines ( Table 1) .
RNA is a polymer made up of four different nucleotides: adenine (A), cytosine (C), guanine (G) and uracil (U), whereas DNA contains thymine (T) rather than U. And as well as the Watson-Crick base pairing found in DNA (A with T, C with G), other forms of base pairing (referred to as non-canonical base pairing) are possible, such as G with A or U, which allows RNA to fold into rigid structural motifs that are distinct from those formed by single-stranded DNA 10, 12, [16] [17] [18] [19] [20] [21] [22] [23] [24] (Fig. 2 ). At present, an RNA strand containing up to 80 nucleotides can be synthesized commercially, and an 80-nucleotide RNA strand can display up to 4 80 (or 10 48 ) different structures. The availability of so many different structural building blocks is an advantage for many applications.
Moreover, RNA typically contains a large variety of singlestranded stem-loops for intra-and/or intermolecular interactions, and these can be used to make 'dovetail' joints between different building blocks, thus removing the need for an equivalent to dowels in RNA nanostructures and nanomachines. Loops and motifs also allow for the construction of a more complicated secondary structure. Furthermore, RNA molecules such as aptamers, ribozymes and short interfering RNA (siRNA) can have special functionalities (see ' Applications of RNA nanotechnology' section).
the emerging field of rna nanotechnology
Peixuan guo 1,2 * Like DNA, RNA can be designed and manipulated to produce a variety of different nanostructures. Moreover, RNA has a flexible structure and possesses catalytic functions that are similar to proteins. Although RNA nanotechnology resembles DNA nanotechnology in many ways, the base-pairing rules for constructing nanoparticles are different. The large variety of loops and motifs found in RNA allows it to fold into numerous complicated structures, and this diversity provides a platform for identifying viable building blocks for various applications. The thermal stability of RNA also allows the production of multivalent nanostructures with defined stoichiometry. Here we review techniques for constructing RNA nanoparticles from different building blocks, we describe the distinct attributes of RNA inside the body, and discuss potential applications of RNA nanostructures in medicine. We also offer some perspectives on the yield and cost of RNA production.
Among the three helices (RNA/RNA, RNA/DNA and DNA/ DNA), the RNA/RNA double helix is the most stable 25, 26 . RNA motifs and modules with special bends or stacks are particularly stable. The thermodynamic stability has been defined as the free energy, G, required for complex formation, or in some cases, to unwind the helix (ΔG 0 = −G 0 helix = G 0 unwind ); thus, the lower the free energy (−G 0 helix ) the complex holds, the more stable it is. Because ΔG 0 is affected by neighbouring sequences, −G 0 helix for RNA is calculated to be lower than DNA 25, 26 based on the nearest-neighbour model (Table 1) . However, under physiological conditions, the RNA helix displays A-type configuration whereas the DNA helix is predominantly B-type. The 2′-OH in RNA ribose locks the ribose into a 3′-endo chair conformation that does not favour a B-helix. Base stacking is governed by van der Waals interaction, which contributes directly to the enthalpy. Though the difference in the stacking interaction is small between DNA and RNA, the sum over numerous base pairs can make a difference to the helix stability. Thus, RNA nanoparticles are more stable thermodynamically than their DNA counterparts. Like DNA tiles, stable RNA helices in solution can be produced using four to six nucleotides of RNA 12 , but in certain cases as few as two nucleotides can promote complex formations in RNA [27] [28] [29] [30] [31] .
Distinct attributes of rna inside the body
Therapeutic particles are initially recognized by cell-surface receptor(s) before being internalized through the plasma membrane into vesicles (called endosomes) that sort the particles for either degradation or recycling. Escaping the endosome is an important consideration for in vivo delivery because most molecules cannot survive its acidic environment, with a pH ranging from 4.3 to 5. 8 (ref. 32) . At this pH, protonation of DNA purine bases leads to their removal (a process known as depurination) and the resulting apurinic DNA is susceptible to cleavage 33 . The higher stability of RNA at low pHs is especially useful in therapy because it means that they will survive in the endosome and disperse throughout the cell after entry (Table 1) .
Another intriguing property of RNA is the possibility of producing self-assembled RNA nanoparticles in vivo. In contrast to DNA, small RNA molecules are transcribed in the cell using DNA as a template. By using an inducible promoter 34 and appropriate terminators for transcription, small RNA molecules can be produced controllably. RNA can be processed into the desired length by including delta ribozymes at both the upstream and downstream terminals for cis-cleavage 35 . Natural RNA nanoparticles such as dimers [36] [37] [38] [39] and hexamers 8, 9 have been discovered in cells. Sequences such as packaging RNA (pRNA) 35 or transfer RNA (tRNA) 40, 41 for guiding the self-assembly of RNA nanoparticles with functionalities such as siRNA 42, 43 , ribozymes 35 , or aptamers 40 can be incorporated in the DNA template in vivo 35 . Small RNAs, such as riboswitch, with regulatory functions [44] [45] [46] [47] in the cell may be viewed as Boolean networks based on logic operations 48, 49 . Input nodes can be seen as RNA nanostructures and the output (for example, the activation of a pathway) is based on logic functions of input RNA concentrations. Numerous small RNA regulators can be used to regulate the in vivo products and functional pathways, with controls by induction or repression through the trans-and cis-actions. Varieties of small RNA can work cooperatively, synergistically, or antagonistically -based on the design -to produce computational logic circuits as conjunctive or disjunctive normal forms, or other kinds of logic operation. By designing the logic network of AND/NOT/OR gates in the cell, an 'RNA computer' can theoretically be implemented and applied to bacterial, yeast and mammalian systems 48, 49 .
techniques for constructing rna nanoparticles
Construction of nanoparticles requires the use of programmable, addressable and predictable building blocks. Self-assembly of RNA building blocks in a predefined manner to form larger two-, three-and four-dimensional (2-, 3-, 4D) structures is a prominent bottom-up approach and represents an important means by which biological techniques and biomacromolecules can be successfully integrated into nanotechnology 12, 50, 51 . Within the realm of self-assembly there are two main subcategories: templated and non-templated assembly. Templated assembly involves the interaction of RNAs with one another under the influence of a specific external force, structure, or spatial constraint. RNA transcription, hybridization, replication, moulding and phi29 pRNA hexameric-ring formation are all in this category. Nontemplated assembly involves the formation of a larger structure by individual components without any external influence. Examples include ligation, chemical conjugation, covalent linkages, loop-loop interactions of RNA such as the HIV kissing loop and the phi29 pRNA dimer or trimer formation 10, 12, [50] [51] [52] . Various approaches available for RNA nanoparticle construction are discussed below (see Fig. 3 for summary) .
The first tactic uses the assembly mechanism of natural RNA nanoparticles that can form specific multimers in vivo. For example, the retrovirus kissing loops facilitate genomic RNA dimerization 36, 37 . The pRNA of the bacteriophage phi29 DNA-packaging motor assembles into dimers and hexamers through hand-in-hand interactions between two right and left interlocking loops 8, 12, 28, 39, 52, 53 . The bcd mRNA of Drosophila embryos forms dimers through handin-arm interactions 38 . E. coli non-coding RNA dsrA assembles into stripe patterns through their built-in palindrome sequence 23 . The assemblies of RNA nanoparticles in vitro that mimic their natural counterparts were reported twelve years ago 8 . The unusual HIV kissing-loop mechanism has also inspired the design of tectoRNA architectures 13, 29 . The second tactic is to import some of the well-developed principles from DNA nanotechnology. Although RNA is different from DNA, there are some common structural and chemical features that can be exploited for progressing RNA nanotechnology.
DNA nanotechnology uses the nature of DNA complementarity for the construction of nanomaterials by means of intermolecular interactions of DNA strands. A variety of elegant shapes have been created with precise control over their geometries, periodicities and topologies [1] [2] [3] (Fig. 2 ). Various crossover motifs have been designed through reciprocal exchange of DNA backbones 3 . Branched DNA tiles have been constructed using sticky ends and crossover junction motifs, such as tensegrity triangles (rigid structures in periodic-array form) 54 and algorithmic self-assembled Sierpinski triangles (aperiodic arrays of fractal patterns) 55 . The DNA tiles can further self-assemble into nanotubes, helix bundles 56 and complex DNA motifs and arrays for positioning nanoparticles, proteins or dyes with precise control, such as polycatenated DNA ladders 57 . Elegant 3D DNA networks using a minimal set of DNA strands with topologies such as cubes, polyhedrons, prisms and buckyballs have also been fabricated based on junction flexibility and edge rigidity 3, 58 . Continuous growth of the tensegrity triangle in the periodic DNA module has resulted in the formation of DNA crystals diffracting to 4-Å resolution 59 . A striking illustration of the addressable and programmable properties of DNA is Rothemund's DNA origami 60 , where a long singlestranded viral DNA is used as a scaffold for binding shorter strands to generate well-defined 2D and 3D configurations. DNA origami was subsequently applied to build 3D boxes that can be locked and unlocked 61 , nano-arrays for label-free detection of substrates 62 and to elucidate the structure of organized proteins 63 . Rationally designed supramolecular DNA assemblies can be conjugated with organic and inorganic molecules, such as conjugation of porphyrins on parallel DNA helix bundles 64 , nanomagnets 65 and elegant nanomachines 58, 66 . Replicable DNA architectures have been achieved to scale-up the production of DNA nanostructures for practical applications by using enzymatic rolling-circle replication, bacterial cells infected with a viral vector 67 , or chemical approaches for amplifying branched DNA arms 68 .
Although the folding properties of RNA and DNA are not exactly the same, the fundamental principles in DNA nanotechnology are applicable to RNA nanotechnology. For example, the use of the three-way junction (3WJ) and four-way junction (4WJ) 18, 29 to build new and diverse RNA architectures is very similar to the branching Figure 1 | approaches to rna nanotechnology. The construction of RNA nanoparticles is a multistep process that starts with a conception step in which the desired properties of the nanoparticle are defined. A computational approach is then applied to predict the structure and folding of the building blocks and the consequences of inter-RNA interactions in the assembly of RNA nanoparticles. After the monomeric building blocks are synthesized (either by enzymatic or chemical approaches), the individual subunits assemble into quaternary architectures by either templated or non-templated methods. The assembled RNA nanostructures are characterized (by atomic force microscope (AFM), electron microscope (EM), gel electrophoresis and so on) to ensure proper folding with desired structural and functional capabilities. After thorough evaluation, the nanoparticles will be used for various applications.
review article approaches in DNA 1, 3 (Fig. 2a,b ,e,f). Both RNA and DNA can form jigsaw puzzles 13, 69 and be developed into bundles 12, 23, 30, 70 by combining elongation and expansion in the x-y direction (Fig. 2a,b,g-j) . The finding that insertion of bulges in the RNA helix leads to the formation of twisted bundles 12 ( Fig. 2i ) was later demonstrated in DNA (Fig. 2g) , revealing that insertions and deletions of bases can form twisted DNA bundles with handedness 70 , thereby illustrating the same basic principle. However, RNA is more rigid in bulge structure owing to non-canonical interactions, whereas in DNA the twisting requires the interaction of two DNA helices with four strands 70 . Recently, RNA cubic scaffolds 71 were constructed using several RNA sequences that do not fold on themselves but self-assemble with one another in a defined manner. This strategy is reminiscent of DNA nanotechnology, but in contrast to DNA strategies, RNA synthesis can be coupled to RNA self-assembly to generate fully assembled RNA cubes during in vitro transcription.
The third tactic is to apply computational methods in the construction of RNA nanoparticles. Computational approaches can be used to guide the design of new RNA assemblies and to optimize sequence requirements for the production of nanoscale fabrics with controlled direction and geometry 37, [72] [73] [74] [75] . In contrast to traditional methods in which raw materials are selected rather than designed for a given application, the next generation of building blocks can be designed a priori for programmed assembly and synthesis. There are two steps involved in building RNA nanoparticles. The first is a computational approach (for example, using Kinefold 72 ) using the spontaneous self-folding property of RNA into defined structures through base-base interactions dependent on their characteristic ∆G (ref. 76 ). The second is the spontaneous assembly of the resulting RNA building blocks into larger assemblies based on the predicted architecture. This creates an effective computational pipeline for generating molecular models of RNA nanostructures. A recent example is the construction of cubic RNA-based scaffolds, whereby RNA sequence designs were optimized to avoid kinetic traps 77 . The fourth tactic is to use the existing RNA structure with known function as building blocks in RNA-nanoparticle construction. Varieties of mechanisms in RNA loop-loop interactions 8, 12, 31 , tertiary architecture contacts 12, 15, 30 and formation of special motifs 12, 21, [29] [30] [31] [78] [79] [80] [81] [82] have been elucidated. Building blocks are first synthesized after computing intra-and intermolecular folding. Nanoparticles are built through spontaneous templated or non-templated self-assembly as planned. A rich resource of welldeveloped databases can be used to extract known RNA structural units for the construction of new RNA nanoparticles with desired properties 37, 83, 84 . Several methods have borrowed the properties of RNA in loop-loop interactions to construct RNA nanoparticles. The first method is based on the structural features of the pRNA of the bacteriophage phi29 DNA-packaging motor 8, 85 , which uses a hexameric RNA ring to gear the machine 28, 86, 87 . The pRNA has been re-engineered to form dimers, trimers, tetramers, hexamers and arrays through hand-in-hand or foot-to-foot interactions between two interlocking loops 12, 52 (Fig. 4) . Dimers are formed using two building blocks with Ab′ (right and left hand, respectively) and Ba′ (Fig. 4b) . Trimers are formed using three building blocks with Ab′, Bc′ and Ca′ 12, 50, 51 (Fig. 4c) . Dimers of an extended configuration (twins) can also be efficiently self-assembled by introducing a palindrome sequence into the 3′-end of the pRNA 12 . These nanoparticles have been used successfully as polyvalent vehicles 50, 87 . e,f, Illustration of various 3D DNA polygons (e) 2 and RNA cubic scaffolds (f) 30, 77 . g, TEM images of DNA bundles 70 . h,i, AFM images of RNA bundles (h) 23 and pRNA arrays (i) 12 . j, 3D model of H-shaped tectoRNA 21 . Figures to deliver a variety of therapeutic molecules (see ' Applications of RNA nanotechnology' and 'Challenges and perspectives' sections) 12, 52 . The use of pRNA as building blocks for the construction of RNA arrays has also been achieved 12 . When three twins, Ab′, Bc′ and Ca′ are mixed, loop-loop interlocking makes the particles grow in three dimensions.
The second method is the RNA 'architectonics' 13 , whereby structural modules specifying bends or stacks can be encoded in artificial RNA sequences for self-assembling higher-order specific shapes of RNA. Examples include RNA filaments 10, 21, 24 (Fig. 2j ), molecular jigsaw-puzzle units called tectosquares 13, 29 (Fig. 2f) and tRNA antiprisms 88 . The third method is the application of 3-and 4WJs that are selected from known RNA structures or motifs 18, 19 to serve as the cornerstone in nanoparticle construction (Fig. 2) 
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. Some examples include: RNA-structural motif (from ribosomal RNA; rRNA) to guide the tetramer assembly of L-shaped tectoRNAs; 3WJ motifs (from 23S rRNA) to construct a T-shaped arrangement of three helices; and tRNA motifs consisting of 4-and 5WJs to fold L-shaped tertiary structures 29, 37 . The fourth method is to assemble non-natural functional RNAs with defined 3D structures using synthetic ribozyme ligase by employing the molecular design of RNA based on the in vitro selection technique 16, 17 . Conformational switch of RNA nanostructures can also be constructed using a peptide-binding RNA structural motif 20 . The fifth method is the use of a palindrome sequence that differs from the sticky end, at the 5′-or 3′-end of the RNA. The molecule will spontaneously assemble through self-annealing of the palindrome sequence immediately after in vitro transcription or chemical synthesis, before purification 12 . This method is useful for the creation of bundles, especially for designing 3D branches. As each of the 11 nucleotides of the A-RNA generates one helical turn of 360°, the angle or the direction of RNA-fibre extension is controllable by varying the number of nucleotides in the helix containing the palindrome sequence.
applications of rna nanotechnology
The versatility of RNA structure, low free energy in RNA annealing, amenability in sequence, options for structure control, and the property of self-assembly make RNA an ideal material for nanotechnology applications. It is possible to adapt RNA to construct ordered, patterned, or preprogrammed arrays or superstructures (Fig. 2h,i) . RNA sequences can mediate the growth of hexagonal palladium nanoparticles 89 ; programmable self-assembling properties of RNA ladders can direct the arrangement of cationic gold nanoparticles; and periodically spaced RNA architectures can serve as a scaffold for nanocrowns 90 . Geometrically symmetrical shapes such as dimers, trimers or polygons can be constructed from RNA 12,13,52 (Fig. 4) . As symmetrical shapes facilitate the formation of crystals, RNA might serve as scaffolds for X-ray crystallography. Furthermore, self-assembly interaction between interlocking loops, self-linkages through a palindrome sequence, the continued growth into a hierarchical structure, and ease in conjugation and biocompatibility make RNA a good candidate for the construction of scaffolds for tissue engineering 12, 21, 23 . Several laboratories have developed RNA aptamers as biosensors 91 . RNA's new role in nanomedicine applications include cell recognition and binding for diagnosis 92 ; targeted delivery through receptor-mediated endocytosis 93 ; and intracellular control and computation through gene silencing and regulation 48, 49 , nuclear membrane penetration, and blood-brain barrier passing 94 . The most important therapeutic RNA moieties are discussed below.
An siRNA 42, 43 helix has 20-25 nucleotides and it interferes with gene expression through the cleavage of mRNA by a protein-RNA . a, pRNA monomers bearing either a ribozyme, a receptor-binding aptamer, or a targeting ligand and detection molecule. Uppercase and lowercase letters represent right and left hand, respectively. Same letter pair (for example, Aa′) indicates complementarity 28 . b, Monomer Ab′ that contains a receptor-binding aptamer and monomer Ba′, which contains an siRNA, assemble to form hand-in-hand dimers. c, Trimers are formed between monomer Ab′ (which contains an RNA aptamer), Bc′ (contains an siRNA) and Ca′ (contains a ribozyme). d, Foot-to-foot dimers form through the palindrome sequence at the end of two Ab′ monomers, with one bearing a targeting ligand and the other a detection molecule. A ribozyme 95, 96 is an RNA molecule that has enzymatic activity. Ribozymes have significant therapeutic potentials capable of regulating gene function by intercepting and cleaving RNA substrates, such as mRNA, or the viral genome of RNA containing a sequence complementary to the catalytic centre of the ribozyme. This discovery also led to the award of the 1989 Nobel Prize to Thomas Cech and Sydney Altman.
RNA aptamers 97, 98 are a family of oligonucleotides with functions similar to that of antibodies in their ability to recognize specific ligands (organic compounds, nucleotides, or peptides) through the formation of binding pockets 92 . Systematic evolution of ligands by exponential enrichment (SELEX) 99 is the method used to screen for the aptamers from randomized RNA pools developed in vitro by Ellington and Szostak 97 and by Tuerk and Gold 98 . Using this technique, various aptamers have been selected for targeting markers relevant to diseases 92, 100, 101 . Riboswitches 102 are RNA components that bind small molecules and control gene expression in response to an organism's needs. As a biological control mechanism, riboswitches can recognize metabolites, induce premature termination of mRNA transcription, block ribosomes from translating mRNAs, cleave mRNAs and even trigger mRNA destruction. Therefore, RNA switches can be re-engineered to create a new generation of controllers regulated by drug-like molecules to tune the expression levels of targeted genes in vivo. Such RNA-based gene-control machines hold promise in future gene therapies by supplying nanoscale cis-acting modulation 103, 104 . Various RNA moieties including siRNAs, ribozymes, antisense RNAs, aptamers and riboswitches, as well as other catalytic or editing RNAs, can be easily fused or conjugated into RNA nanoparticles (Fig. 4) . The advantages of RNA nanomedicine include: (1) self-assembly (see 'Techniques for constructing RNA nanoparticles' section for self-assembly and self-processing in vivo); (2) multivalency; (3) targeted delivery; (4) protein-free; (5) nanoscale size; (6) controlled synthesis with defined structure and stoichiometry; and (7) combining therapy and detection of therapy effects into one particle.
Bottom-up assembly of RNA can lead to multivalency 51 . Each subunit may be separately functionalized to carry different therapeutic payloads, reporters and/or targeting ligands ( Fig. 2d; Fig. 4a ). Cell-type-specific delivery allows a lower concentration of the drug to be administered, thus reducing the side effects. The multivalent approach is similar to that of cocktail therapy, in which a mixture of drugs is used to produce a synergistic effect. The multivalency offers a further advantage in that therapy and detection of therapeutic effects may be combined into one nanoparticle conducted under a single administration 12, 50, 51 . At present, a variety of other polyvalent nanoparticles have been developed; however, producing homologous particles and consistent reproduction of copy numbers within the population is challenging. Any uncertainty in structure and stoichiometry could cause unpredictable side effects or non-specific toxicity. Using RNA nanotechnology, the production of homogeneous nanoparticles can be 'manufactured' with high reproducibility, and defined structure and stoichiometry, thus facilitating quality and safety control.
The size of RNA particles on the nanometre scale is another advantage. For effective delivery to diseased tissues, many studies suggest that particles ranging from 10-50 nm are optimal for a non-viral vector because they are large enough to be retained by the body yet small enough to pass through the cell membrane by means of endocytosis, mediated by the cell-surface receptors 105 . Nanoparticle delivery has the potential to improve the pharmacokinetics, pharmacodynamics, biodistribution and safety of this newly emerging modality.
The protein-free nature will avoid the induction of antibodies, thus allowing repeated administration for the treatment of chronic diseases including cancers, viral infections and genetic ailments. Moreover, RNA nanoparticles are classified by the United States Food and Drug Administration (FDA) as chemical rather than biological entities, which will speed up the FDA approval.
The feasibility of RNA nanotechnology in disease therapy has been exemplified in the phi29 pRNA therapeutic system 14, 35, 50, 51, 106, 107 . Incubation of the synthetic polyvalent RNA nanoparticles containing receptor-binding aptamers or ligands resulted in cell binding and entry of the incorporated therapeutics, subsequently modulating apoptosis 50, 51 . The delivery efficiency and therapeutic effect were later confirmed in animal trials 50, 51 . The 3D design, circular permutation, folding energy alteration and nucleotide modification of RNA were applied to generate RNase-resistant RNA nanoparticles with low toxicity and to ensure processing of the chimeric RNA complexes into siRNA by Dicer after delivery.
challenges and perspectives
RNA nanoparticle construction involves conjugation of functionalities, crosslinking of modules, labelling of subunits and chemical modification of nucleotides. Methods of synthesizing RNA building blocks include both chemical and enzymatic approaches. Although great progress has been made, improvements are much needed.
Prediction of RNA structure or folding for particle assembly remains a challenge. Owing to the unusual folding properties such as non-canonical base pairing, the rules that elucidate RNA folding are yet to be sorted out. At present, using the RNA 2D prediction program by Zuker, typically only 70% of the 2D folding prediction is accurate, based on experimental data 74, 75 . Clearly, predicting the RNA 3D and 4D structures is even more elusive. Computer-aided programs in RNA-structure prediction and those for computing the intermolecular interactions of RNA subunits for quaternary nanostructure formation are still to be explored.
Natural RNA is sensitive to RNase and is especially unstable in serum or in the body. This instability has long hindered its application as a construction material. Improving the stability of RNA has progressed rapidly; chemical modification of the base (for example, 5-Br-Ura and 5-I-Ura), phosphate linkage (for example, phosphothioate, boranophosphate), and/or the C2′ (for example, 2′-fluorine, 2′-O-methyl or 2′-amine) 108 have all been explored. Other attempts include peptide nucleic acids, locked nucleic acids and their respective derivatives polycarbamate nucleic acids 109 or locked nucleic acids with a bridge at different positions (2′-4′, 1′-3′) 110 . The 3′-end capping also improved the base pairing selectivity in duplex formation 111 . For all these methods, the 2′-fluorine modification is the most appraisable because it has minimal detrimental effect on RNA folding and function 112 . Loop-loop interaction is one approach to assemble quaternary RNA nanoparticles; however, dissociation of loops can occur when the concentration is reduced. Crosslinking agents, such as psoralen, nitrogen mustard derivatives and transition metal compounds 113 can promote the formation of stable RNA complexes. Recent advancements include various bifunctional agents separated by linkers and phenolic derivatives 114 to increase the efficiency of crosslinking. Long-range (> 9 Å) and short-range (1.5 Å) photoaffinity crosslinking can be achieved using azidophenacyl derivatives and thionucleosides, such as 6-thioguanosine and 4-thiouridine, respectively.
For fluorescent labelling, single conjugation of fluorophores at the 5′-or 3′-end is preferable to prevent physical hindrance. End labelling is not difficult with chemical synthesis of small RNA, however, it is challenging for long RNA requiring enzymatic methods.
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To meet this challenge, guanosine monophosphate (GMP) or adenosine monophosphate (AMP) derivatives that can only be used for transcription initiation, but not for chain elongation, have been used. Fluorescent RNA can also be easily synthesized in vitro with T7 RNA polymerase using a new agent tCTP 115 . The challenges of in vivo computation using RNA 48, 49 include scaling the logic operations with a large number of inputs, extending input signal types, and eliminating nonspecific actions resulting in targeting unexpected or undesired pathways.
The results of modification related to RNA folding and in vivo toxicity of the nucleotide derivatives remain to be explored. Owing to metabolism and biocompatibility issues, the most stable RNA might not necessarily be the most desirable; retention of particles within an appropriate time period is more attractive.
The most challenging aspect of RNA therapeutics is the yield and cost of RNA production. Commercial RNA chemical synthesis can offer only 40 (conservative) to 80 nucleotides with low yield. Acetalester 2′-OH protecting groups, such as pivaloyloxymethyl, have been reported to enhance chemical synthesis of RNA 117 . RNase ligase II has been shown to be a good alternative over the traditional T4 DNA ligase to generate longer RNA by ligation of two shorter synthetic RNA fragments 116 . In enzymatic synthesis, heterogeneity of the 3′-end has been an issue 117 ; this can be addressed by extending the transcribed sequence beyond the intended end and then cleaving the RNA at the desired site using ribozymes, DNAzymes, or RNase H [116] [117] [118] . Large-scale RNA complexes produced in bacteria escorted by a tRNA vector have also been reported 40, 41 . Based on the rapid reduction of cost over the history of DNA synthesis, it is expected that the cost of RNA synthesis will gradually decrease with the development of industrialscale RNA production technologies.
In conclusion, natural or synthetic RNA molecules can fold into predefined structures that can spontaneously assemble into nanoparticles with numerous functionalities. The field of RNA nanotechnology is emerging but will play an increasingly important role in medicine, biotechnology, synthetic biology and nanotechnology.
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